Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proto-oncogene c-Rel is a transcription factor and member of the NF-κB family that plays a critical role in the immune system, particularly in lymphocyte function. It regulates various cellular processes including survival, proliferation, and immune responses. Dysregulation of c-Rel is associated with cancer, autoimmune diseases, and immunodeficiency, making it a potential therapeutic target.
Modulation of c-Rel activity to influence gene expression and cellular function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proto-oncogene c-Rel (c-Rel).